Wolverine Trading
TNDM icon

Wolverine Trading’s Tandem Diabetes Care TNDM Stock Holding History

Wolverine Trading’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$440K Buy
37,300
+21,100
+130% +$286K ﹤0.01% 3853
2025
Q2 		$307K Buy
+16,200
New +$321K ﹤0.01% 3452
2025
Q1 		– Sell
-26,200
Closed -$966K – 5841
2024
Q4 		$966K Sell
26,200
-1,100
-4% -$37.2K ﹤0.01% 2687
2024
Q3 		$1.16M Buy
27,300
+6,300
+30% +$267K ﹤0.01% 2205
2024
Q2 		$846K Buy
+21,000
New +$876K ﹤0.01% 2350
2024
Q1 		– Sell
-14,200
Closed -$420K – 5304
2023
Q4 		$420K Buy
+14,200
New +$295K ﹤0.01% 3133
2023
Q1 		– Sell
-13,500
Closed -$607K – 4949
2022
Q4 		$607K Sell
13,500
-9,100
-40% -$412K ﹤0.01% 2205
2022
Q3 		$1.12M Buy
22,600
+6,700
+42% +$367K ﹤0.01% 1849
2022
Q2 		$957K Sell
15,900
-14,800
-48% -$1.21M ﹤0.01% 1959
2022
Q1 		$3.58M Sell
30,700
-9,800
-24% -$1.14M ﹤0.01% 1295
2021
Q4 		$6.15M Sell
40,500
-1,400
-3% -$189K 0.01% 1015
2021
Q3 		$5.03M Sell
41,900
-11,000
-21% -$1.21M 0.01% 1291
2021
Q2 		$5.3M Buy
52,900
+21,000
+66% +$1.87M 0.01% 1087
2021
Q1 		$2.71M Sell
31,900
-47,100
-60% -$4.38M ﹤0.01% 1640
2020
Q4 		$7.54M Sell
79,000
-25,800
-25% -$2.66M 0.01% 829
2020
Q3 		$11.8M Buy
104,800
+5,100
+5% +$536K 0.03% 468
2020
Q2 		$8.76M Buy
99,700
+23,600
+31% +$1.88M 0.02% 523
2020
Q1 		$5.18M Buy
+76,100
New +$5.33M 0.02% 744
2019
Q4 		– Sell
-117,400
Closed -$6.9M – 5207
2019
Q3 		$6.9M Sell
117,400
-17,300
-13% -$1.1M 0.02% 690
2019
Q2 		$8.69M Buy
134,700
+36,700
+37% +$2.37M 0.02% 598
2019
Q1 		$6.22M Sell
98,000
-44,400
-31% -$2.33M 0.02% 751
2018
Q4 		$5.31M Sell
142,400
-25,600
-15% -$904K 0.02% 782
2018
Q3 		$7.2M Buy
+168,000
New +$5.87M 0.02% 742
2017
Q1 		– Sell
-1,000
Closed -$22K – 4989
2016
Q4 		$22K Buy
+1,000
New +$38.5K ﹤0.01% 4304

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
FGP
Freestone Grove Partners San Francisco, California $14.2B AUM 24.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wolverine Trading's TNDM Position: Q2 2025 in Review

Wolverine Trading sold out of Tandem Diabetes Care (TNDM) in Q2 2025, closing a stake of 10,973 shares — an estimated $217K sold.

Wolverine Trading first reported a position in TNDM in Q1 2017 and held it in 17 quarters. The position peaked at $4M in Q3 2018. 270 funds tracked by Wall St. Rank hold TNDM as of Q2 2025.

  • Wolverine Trading reported no remaining Tandem Diabetes Care position as of Q2 2025 after selling out during the quarter.
  • Wolverine Trading sold 10,973 Tandem Diabetes Care shares in Q2 2025, an estimated $217K.
  • Wolverine Trading first reported a position in Tandem Diabetes Care in Q1 2017 and held it in 17 quarters.
  • Wolverine Trading's Tandem Diabetes Care position peaked at $4M in Q3 2018.
  • 270 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2025.

Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.